Fellows
Fellows in Committee on Clinical Pharmacology and Pharmacogenomics
Mohamed Ali, PhD
Fellow, Committee on Clinical Pharmacology and Pharmacogenomics
Research Interest:
Clinical Pharmacology and Translational Science. Focus on exposure-response analysis, PK modeling, and dose optimization through alternative dosing strategies in oncology, particularly within early-phase clinical trials to enhance efficacy, safety, and cost-effectiveness.
Research Mentor: Mark Ratain, MD
Robert Cameron, MD, PhD
Fellow, Committee on Clinical Pharmacology and Pharmacogenomics
Research Interest: Identification of metabolic vulnerabilities within tumors to develop new therapeutic targets and combinations
Research Mentors: Brandon Faubert, PhD and Marina Garassino, MD
Joseph Cannova, MD, PhD
Fellow, Committee on Clinical Pharmacology and Pharmacogenomics
Research Interest: Investigating mechanisms of recurrent cytogenetic alterations in therapy-related myelodysplastic syndrome and acute myeloid leukemia with loss of chromosome 7 domains.
Research Mentor: Michael Drazer, MD, PhD
Youngwoo Cho, PharmD
Fellow, Committee on Clinical Pharmacology and Pharmacogenomics
Research Interest: Translation of pharmacogenomics (PGx) in clinical oncology, early-phase clinical development, and pharmacokinetics (PK) and pharmacodynamics (PD) of immunotherapy
Research Mentor: Peter H. O’Donnell, MD
Alyssa Kim, PharmD, PhD
Fellow, Committee on Clinical Pharmacology and Pharmacogenomics
Research Interest: Optimizing and translating therapeutic strategies for immunoevasive and therapy-resistant tumors; preclinical model design; advancing preclinical findings toward clinical practice
Research Mentor: Kunle Odunsi, MD, PhD
Arooj Mohammed, MD, MPH
Fellow, Committee on Clinical Pharmacology and Pharmacogenomics
Research Interest: Investigating immune-related adverse events (irAEs), advancing pharmacovigilance of immunotherapy, and modeling exposure–toxicity of immune checkpoint inhibitors (ICIs).
Research Mentor: Pankti Reid, MD, MPH and Mark Ratain, MD
Sulin Wu, MD, PhD
Fellow, Committee on Clinical Pharmacology and Pharmacogenomics
Research Interest: Therapeutic design informed by germline and somatic profiles associated with immune therapy resistance and intolerance; Biomarker discovery; Early phase trials
Research Mentor: Olufunmilayo Olopade, MD, FACP